Will stem cells be able to rejuvenate in the future?

What should we pay attention to in the treatment of stem cells?

After bone marrow transplantation of hematopoietic stem cells, is the DNA of the recipient’s blood consistent with that of the recipient?

Can mesenchymal stem cells be mass produced?

Will allogeneic injection of stem cells produce rejection?

What are the possibilities of research and application of stem cells in orthopaedics?

On August 18, 2019, Future Forum hold a meeting about Future Science “Imagination and Reality of Returning Aged to Children “. During the questioning session, audience questions emerged.

In the days of Leonardo Da Vinci and navigators, the average life expectancy of humans was 35 years; At the launch of Voyager, the average life expectancy of humans was 64 years.

In July this year, the latest data of the National Health Commission showed that in 2018, the average life expectancy of Chinese residents reached 77 years, while the real healthy life expectancy was only 68.7 years. By the end of 2018, there were 249 million elderly people aged 60 and over in China, accounting for 17.9% of the total population. Among them, more than 180 million elderly people suffered from chronic diseases, and 75% suffered from one or more chronic diseases.

How can people improve their quality of life on the basis of prolonged life? In recent years, stem cells have gradually become a focus of public concern in the field of health. It is hoped that stem cells can be used to treat diseases, even resist aging, and remain young forever.

Stem cells can be used as models, tools and drugs. In the practical application process, attempts in the field of science from in vitro culture to pre-clinical research based on animal experiments to clinical application are actually a long process. In the development of stem cell research, scientific thinking, industrial planning, management and publicity still need to be strengthened. Li Wei, a researcher at the Institute of Zoology, Chinese Academy of Sciences and deputy director of the State Key Laboratory of Stem Cell and Reproductive Biology, said.

Li Wei believes that regenerative medicine is expected to trigger a new round of medical revolution.

At present, the stem cell research team of the Institute of Zoology of the Chinese Academy of Sciences has started and completed several clinical studies of stem cell therapy for Parkinson’s disease on the basis of 12 years of basic research and preclinical research.

After follow-up, we found that the current stage of research is very safe, and this stage of progress is a great encouragement for the steady development of regenerative medicine. Li Wei said that although stem cell research and development will be a big change for health and life, it still needs a process, sufficient confidence and patience, positive optimism but not aggressive. It is expected that within a relatively short period of time, regular products of stem cell drugs approved by the State Food and Drug Administration will be marketed in the next five to ten years.

PRP(Platelet Rich Plasma) is prepared through blood centrifugation to obtain high concentration Platelet Plasma. SANLI@ PRP can effectively prevents platelet loss and accelerate platelets to produce growth factors. These growth factors form platelets participate in the migration, differentiation and proliferation of stem cells, as well as to stimulate cells such as fibroblasts and endothelial cells. PRP is widely used in cosmetics, orthopedics, stomatology and other fields. For more information of PRP, please go to https://www.sanlimedical.com/product-category/prp/.